Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on 18F-FDG, 68Ga-DOTATATE, and 68Ga-FAPI04 PET/CT.
Clin Nucl Med
; 47(1): e79-e80, 2022 Jan 01.
Article
em En
| MEDLINE
| ID: mdl-34392280
ABSTRACT
ABSTRACT Herein, we present a 72-year-old woman with metastatic thymic carcinoma, referred for salvage peptide receptor radionuclide therapy with 177Lu-DOTATATE after completing all treatment options according to current clinical practice and guidelines. However, the patient was not eligible for 177Lu-DOTATATE peptide receptor radionuclide therapy and underwent 68Ga-FAPI04 PET/CT to assess the potential for a FAP-targeted therapy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Compostos Organometálicos
/
Timoma
/
Neoplasias do Timo
Tipo de estudo:
Guideline
Limite:
Aged
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article